Consequently, Amarin applied for FDA approval to sell Vascepa for this purpose. Vascepa’s success has helped take AMRN from penny stock status less than 18 months ago to the current AMRN stock price …
More For Now, Amarin Stock Is a Gamble on FDA Approval Videos